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Introduction
The human genome is not cast in stone; it is believed to
undergo changes with every generation. Besides pater-
nal and maternal contributions to the genome of an indi-
vidual human being, de novo changes may occur during
the earliest steps of human reproduction, i.e., during
generation of germ cells in early human development,
or a later time point as we witness genetic changes in
somatic cells that spur off cancer development. 
Looking at chromosomal changes from the stand-
point of reproductive genetics, one notes that congeni-
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tal anomalies which include balanced and Robertson-
ian translocations as well as chromosomal inversions
occur in as much as 1.4% of the general population [1].
Among infertile couples and IVF patients with recur-
rent abortions, such structural chromosome abnormal-
ities have been observed at even higher rates [1-2].
Stern and colleagues, for example, reported balanced
translocations in 0.6% of all infertile couples, but in
3.2% and 9.2% of couples who failed more than 10
IVF cycles or experienced three or more consecutive
first-trimester abortions, respectively [3]. 
A common consequence of balanced reciprocal
translocations in carriers without clinical disease
symptoms is an increased fraction of germ cells with
numerical chromosome aberrations. This has been
attributed to disturbed homologue pairing during
meiosis or precocious chromatid separation [4-5]. As 
a clinical manifestation of this problem, patients suffer
from reduced fertility, infertility or a history of repeat-
ed miscarriages [6].
During the course of IVF, PGD can now be offered
to affected couples as an alternative to prenatal diag-
nosis and medically-indicated termination of pregnan-
cies with chromosomally-unbalanced fetuses [7-9]. If
a sufficient number of fertilized normal embryos is
available for transfer, PGD also provides an efficient
option to put an end to a familial disease [6]. Howev-
er, the greatest benefit of PGD is the reduction of spon-
taneous abortions [10]. On the other hand, the preg-
nancy rates after PGD among couples carrying non-
Robertsonian translocations may not improve much
due to high prevalence of abnormal embryos [6, 11].
The conventional cytogenetic methods, i.e., chro-
mosome banding procedures, are challenged when
dealing with very subtle chromosome rearrangements,
particularly de novo abnormalities in newborns. Even
more limiting, banding analysis requires cells in
metaphase, but the blastomeres biopsied from day 
3 embryos can be in any stage of the mitotic cell cycle. 
Fortunately, fluorescence in situ hybridization
(FISH), a technique to mark specific DNA sequences
in interphase or metaphase cells, is sensitive and spe-
cific enough to elaborate these objectives. A few years
ago, we proposed to map breakpoints with yeast artifi-
cial chromosome (YAC) probes spaced in intervals of
roughly 8-15 megabasepair (Mbp) along the target
chromosomes [12-14]. The target interval was nar-
rowed through repeated cycles of clone selection and
hybridization until a clone had been found that
spanned the breakpoint [13] (Fig. 1). Breakpoint-span-
ning YACs and adjacent, non-chimeric clones were
then assembled into larger contigs to increase FISH
efficiency. Although this proved to be a straightfor-
ward approach for breakpoint mapping in some
patients [12,15-16], the precise determination of
breakpoint locations often became a rather time-con-
suming process plagued by errors in the published
physical maps and YAC clone chimerisms [13,17].
The bacterial artificial chromosome (BAC) clone
libraries, able to maintain DNA fragments of several
hundred kb, show a very small fraction of chimeric
clones, if any [18-19]. As probes in cytogenetic analy-
ses, BACs owe their popularity to several features: rel-
atively high stability, large DNA insert-to-vector size
ratio, ease of handling and rapid growth [19-22]. Com-
pared to the use of YACs, the latter is expected to
reduce the length of each mapping cycle (Fig. 1), thus
accelerating the in situ delineation of chromosomal
translocation breakpoints and preparation of break-
point-specific DNA probes [13]. Furthermore, we
decided to use sets of overlapping BAC clones form-
ing 'contigs' or 'pools' instead of single clones, since
this minimizes the rates of so-called 'FISH failures' or
uninformative results [8-9,23-25]. The present article
describes the strengths of BAC clone pooling strate-
gies expediting probe preparation for PGD.
Materials and methods
Tissue samples. Prior to our study, lymphocytes from the 31-year
old female IVF patient T-0512 were analyzed by G-banding. The
karyotype 46,XX, t(4;13)(q21.3;q21.2) suggested a balanced,
reciprocal translocation as shown in Fig. 2.
Metaphase spreads were made from short-term cultures of
peripheral blood following published procedures [26-27]. Briefly,
lymphocytes from an anonymous normal male donor or patient T-
0512 were grown for 72 h in RPMI 1640 (Invitrogen, Carlsbad,
CA) 10% fetal bovine serum, 1% penicillin/streptomycin and 2%
phytohemagglutinin (PHA, HA-15; Abbott Molecular, Inc, Des
Plaines, IL). Prior to harvest, cells were blocked in mitosis in a 
30 min treatment with colcemid (0.12 µg/ml, Invitrogen, San
Diego, CA) and incubated in 75 mM KCl for 15 min at 37°C. The
cells were then spun down, and approximately 107 cells were incu-
bated in 5 ml of freshly prepared fixative (acetic acid:methanol, 
1:3 (v/v). The fixation step was repeated twice, before the cells
were dropped on ethanol-cleaned glass slides. Slides were aged for
a minimum of 1 week in air at 20°C, then sealed in plastic bags and
stored at -20°C until used.
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Fig. 1. The procedure to map breakpoint locations in translocation
carriers begins with a rough definition of the breakpoint interval
followed by cycles of probe selection, mapping on to patient
metaphase chromosomes and interval refinement. The second
phase, probe optimization, begins when a breakpoint-spanning
probe has been identified.
Fluorescence in situ hybridization. Using information in pub-
licly available databases (http://genome.ucsc.edu/ and
http://www.ncbi.nlm.nih.gov/gquery/gquery.fcgi), we selected
BAC clones from the Roswell Park Cancer Institute (RPCI) library
RP11 that map to the estimated breakpoint interval or to adjacent
chromosome bands. For initial mapping of individual clones, BAC
DNA was isolated from 10 ml bacterial overnight cultures contain-
ing 12.5 µg/ml chloramphenicol (Sigma, St. Louis, MO) using an
alkaline lysis and isopropanol DNA precipitation [28]. Briefly, cell
pellets resuspended in 10 ml of phosphate-buffered saline (PBS)
containing 50μg/ml lysozyme (Sigma) and lyzed in sodium
hydroxide (0.2 M NaOH, 1 % SDS). After neutralization by addi-
tion of 3 M NaOAc and pelleting of bacterial DNA, BAC DNA
was precipitated in 2-propanol, washed in cold 70% ethanol, and
resuspended in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0).
Next, the DNA was extracted once with phenol:chloroform, pre-
cipitated with isopropanol, and resuspended in 20-40 µl sterile
water. The DNA concentrations were determined by Hoechst
33342 fluorometry using a TKO100 instrument (Hoefer, San Fran-
cisco, CA) [28]. The BAC-derived probe DNA (typically 1-2 µl of
DNA in a 10 µl reaction) was labeled via random priming follow-
ing the instruction of the kit manufacturer (BioPrime Kit, Invitro-
gen) [29]. For non-isotopic, indirect labeling biotin-14-dCTP
(Invitrogen), digoxigenin(dig.)-11-dUTP (Roche Molecular Sys-
tems, Indianapolis, IN), Spectrum Green or Spectrum Orange
(Abbott) was incorporated into the DNA [30]. 
The preparation of DNA probes representing BAC pools was
performed in essentially the same way with the following modifi-
cation: individual BACs were grown overnight in 10 ml of broth
containing 20 µg/ml chloramphenicol. Then, 5 ml from each cul-
ture was combined in the desired pool, the cells were spun down,
resuspended in 10 ml PBS containing 50 µg/ml lysozyme, and
DNA was isolated and labeled as described above. 
For an initial assessment of the breakpoint location using indi-
vidual BACs, we selected 60 clones from the Roswell Park Cancer
Institute (RPCI) 'RP11' library (Oseogawa et al. [20]) spread out
over the following intervals: for chromosome 4 from 79.7 Mbp to
91.3 Mbp, i.e., from band 4q21.2 to band 4q23. Probe clones for
chromosome 13 were selected to map between 57.4 Mbp and 
66.8 Mbp, which corresponds to bands 13q21 and 13q23, respec-
tively. Prior to hybridization of DNA probes to patient samples, all
probes were tested on normal male metaphase spreads to ensure
sufficient signal strength, correct cytogenetic map positions and
absence of chimerism [17].
For delineation of the T-0512 breakpoint on the long arm of
chromosome 4, we chose 13 BACs from the RP11 library that
cover the region between 89.4 Mbp and 91.2 Mbp. The 
BAC-derived DNA probes were combined in pools as shown in
Table 1: Pool 4-1 is a five BAC contig centered on clone RP11-2I7
at 89.7 – 89.9 Mbp. Pool 4-2 binds distal of Pool 4-1 and covers
the interval from 90.2 Mbp to 90.6 Mbp on chromosome 4q. Pool
4-3 is comprised of 4 clones, which map between 90.8 Mbp and
91.2 Mbp, i.e., distal of Pools 4-1 and 4-2. Pools 4-1 and 4-2 cover
unique, non-overlapping regions of about 795 kb and 400 kb,
respectively. The chromosome 4-specific probes or probe pools
were labeled via random priming in separate reactions, then com-
bined as needed for in situ hybridization experiments. We also pre-
pared eight chromosome 13-specific BAC pools: Pools 13-1 to 
13-6 cover part of the long arm of chromosome 13 from band
q21.2 to band q21.33, while Pool 13-7 comprised of 2 BACs which
map in band 13q22.3 between 77.3 Mbp and 77.5 Mbp serves as a
distal reference probe (Table 2).
For FISH, we combined 1 μl of each probe, 1 μl of human COT-
1™ DNA (1 mg/ml, Invitrogen), 1 l of salmon sperm DNA (10
mg/ml, Invitrogen) and 7 μl of a hybridization master mix (78.6%
formamide (Invitrogen), 14.3% dextran sulfate in 
1.43x SSC, pH 7.0 (20x SSC is 3 M sodium chloride, 300 mM tri-
sodium citrate) [30] and denatured the mixture in a waterbath at
76°C for 10 min. Then, the hybridization mixture was incubated for
30 min at 37°C to pre-anneal blocking DNA with the probes, while
the slides were denatured for 4 min at 76°C in 70% formamide/2x
SSC, pH 7.0, dehydrated in a 70%, 85%, and 100% ethanol series
for 2 min each step, and allowed to air dry. The hybridization mix-
ture was then pipetted on to the slides and sealed with rubber
cement under a 22 × 22 mm2 coverslip. Following overnight
hybridization at 37°C and coverslip removal, the slides were
washed twice in 50% formamide/2x SSC at 45°C for 10 min each
followed by two washes in 2x SSC at 21oC. Cells were then incu-
bated briefly in PNM (5% nonfat dry milk, 1% sodium azide in PN
buffer (0.1 M sodium phosphate buffer, pH 8.0, 1% Nonidet-P40
(Sigma))) for 10 min at 21°C, before bound probes were detected
with fluorescein-conjugated avidin DCS (Vector, Burlingame, CA)
or anti-digoxigenin-rhodamine (Roche) [28]. Finally, the slides
were mounted in 4',6-diamidino-2-phenylindole (DAPI) 
(0.5 µg/ml; Calbiochem, La Jolla, CA) in antifade solution [28,30].
Image acquisition and analysis. Fluorescence microscopy was
performed on a Zeiss Axioskop microscope equipped with a filter
sets for observation of Texas Red/ rhodamine. FITC or DAPI
detection (ChromaTechnology, Brattleboro, VT). Images were col-
lected using a CCD camera (VHS Vosskuehler, Osnabrueck, FRG)
and processed using Adobe Photoshop® software (Adobe Inc.,
Mountain View, CA).
Results
Using probes prepared from 60 individual BAC
clones, hybridizations with normal or patient
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Fig. 2. Schematic diagram of the karyotypic abnormalities in case
T-0512 initially reported as t(4;13)(q21.3;q21.2). Dotted horizon-
tal lines indicate the approximate breakpoint locations at 4q22.1
and 13q21.3 as determined by FISH, and translocated parts are
bracketed. The hatched and open boxes represent the breakpoint-
spanning probe contigs for chromosome 4 and 13, respectively.
Please note that the contigs are split unevenly by the translocation.
metaphase spreads showed disappointing results: 20 of
60 clones failed to produce informative hybridization
signals (data not shown). However, clones that gave
analyzable signals on t(4;13) cells suggested a break-
point on the long arm of chromosome 4 distal of clone
RP11-2I7 at 89.7-89.8 Mbp and proximal of BAC
clone RP11-115D19 at 90.7-90.9 Mbp, i.e., roughly
within a 1 Mbp interval in band 4q22.1 (Table 1).
Based on the FISH results with individual clones, we
changed our mapping strategy and replaced individual
clones with selected contiguous sets of BACs. To
increase hybridization efficiencies and obtain a first
assessment of the location of the chromosome 4-spe-
cific breakpoint, we pooled three Spectrum Green-
labeled probes (RP11-2I7, RP11-496N17 and RP11-
502A23) with four Spectrum Orange-labeled probes
prepared from clones RP11-115D19, RP11-395B6,
RP11-67M1 and RP11-350B19 (Pool 4-3, Table 1).
The FISH results demonstrated that all green fluores-
cent probes bound proximal of the breakpoint and gave
signals on the normal homologue of chromosome 
4 and the der(4) (Fig. 3A). The hybridization of our
pool of Spectrum Orange-labeled probes resulted in
red signals exclusively on the normal chromosome 4
and the der(13) indicating that Pool 4-3 (Table 1)
mapped entirely distal of the breakpoint (Fig. 3A). Due
to close proximity of green and red signals probes, the
superimposed FISH images appear partially yellow in
the pseudo-RGB pictures in Fig. 3.
With the breakpoint on chromosome 4 in T-0512
located between clones RP11-502A23 and RP11-
115D19, we prepared one large pool of dig.-labeled
DNA probes comprised of all five probes that map to
Region 4-1 and four clones from Region 4-2 (Table 1).
The FISH results showed that this contig bound to the
normal chromosome 4, as well as both derivative chro-
mosomes, thus resulting in a probe that not only covered,
but extended the chromosome 4 breakpoint (Fig. 3B). 
The FISH mapping experiments of individual BAC
clones for chromosome 13 were plagued by hybridiza-
tion failures, too, but allowed to place the T-0512
breakpoint between the proximal clone RP11-16M6 at
~57.4 Mbp and the three BAC clones RP11-10M21,
RP11-138D23 and RP11-346A3, which map to 66.165
Mbp – 66.753 Mbp (Table 2). This chromosome 
13-specific interval measures about 9 Mbp.
A first FISH experiment to determine the chromo-
some 13-specific breakpoint location used BAC pools
comprised of biotin-labeled DNA from Pools 13-1, 
13-3, 13-5 and 13-7 and dig.-labeled probes made
from Pools 13-2, 13-4 and 13-6 (Table 2). Hybridiza-
tion of these 'superpool' DNA probes to normal male
metaphase spreads showed strong, specific signals on
both homologues of chromosome 13 without notice-
able cross-hybridization to other chromosomes (not
shown). Hybridization of the same combination of
chromosome 13-specific probe pools to metaphase cell
from T-0512 showed strong hybridization signals 
on the normal chromosome 13 and the der(13) as well
as on the der(4) (Fig. 3C). Since all three hybridization
domains showed green and red fluorescent signals, this
first BAC pool hybridization confirmed our hypothe-
sis, i.e., the interval covered by Pools 13-1 to 13-6
extents onto both sides of the breakpoint. It also sug-
gested a breakpoint between Pools 13-2 and 13-6, i.e.,
around 60.6 – 67.8 Mbp.
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Table 1. Location of BAC pools on chromosome 4q22.1.
a Unique position information is estimated from the Human Genome Reference DNA Sequence, Mapviewer build 36.3 at 
http://www.ncbi.nlm.nih.gov/projects/mapview/.
b The insert sizes were taken from information available at the NCBI Clone Registry at 
http://www.ncbi.nlm.nih.gov/genome/clone/clname.cgi?stype=Id&list=209311&TransHist=0
c BAC size was determined via BLAST search at http://blast.ncbi.nlm.nih.gov/.
A second hybridization of BAC pools to patient
metaphase spreads combined the two dig.-labeled
pools for chromosome 4 (4-1, 4-2; Table 1) with a
combination of biotinylated DNA probes prepared
from Pools 13-4, 13-5, 13-6, and the newly added
Pool 13-5.5 (Table 2). The chromosome 4- and 13-
specific probes were detected in red and green,
respectively, and all four chromosomes of interest
(4, 13, der(4), der(13)) could be identified by their
DAPI banding pattern and FISH signals (Fig. 3D-F).
For example, the image in Fig. 3E shows three red
signals: one on the normal chromosome 4 and two on
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* Unique position information is estimated from the Human Genome Reference DNA Sequence, Mapviewer build 36.3 at
http://www.ncbi.nlm.nih.gov/projects/mapview/.
Table 2. Location of BAC pools on chromosome 13q.
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Fig. 3. Hybridization of BAC pools for rapid delineation of chromosome breakpoints. (A) Hybridization of chromosome 4-specific BAC
pools to patient metaphase cells demonstrates specific binding to the target region on the long arm of chromosome 4. The pseudo-RGB
image shows the localization of proximal (green) and distal (red) BACs on DAPI counterstained metaphase chromosomes. (B) Hybridiza-
tion of the optimized BAC contig for chromosome 4 marks the normal homologue and both derivative chromosomes in this metaphase
spread from patient T-0512. (C) Hybridization of seven probe pools for chromosome 13 generates signals on the normal homologue and
the der(13) as well as on the der(4) indicating that probes bind proximal and distal of the breakpoint on chromosome 13. The insert shows
an enlarged, partial picture of DAPI channel with the arrow pointing at the der(13). (D-F) Combined hybridization of the chromosome 
4-specific BAC pools (red) and Pools 13-4 to 13-6 (green) indicated the distal position of the chromosome 13-specific probes. The DAPI,
red, and green fluorescence images are shown in D, E, and F, respectively. (G) Combined hybridization of Pool 13-3 (green) and the chro-
mosome 4 contig (red) shows a strong green signal on the der(13)(arrowhead) and a weak green signal on the der(4)(arrow). H-I)
Hybridization of the optimized probe sets for chromosomes 13 (green) and 4 (red) to metaphase and interphase cells. Image (H) shows
the superposition of probe signals with the inverted DAPI image in a T-0512 metaphase spread. In interphase nuclei (I), der(4) and der(13)
can be differentiated by the strength of the red-green fluorescence signals.
derivative chromosomes der (4) and der(13) as
expected for a probe pool that spans the breakpoint
on chromosome 4. We also noted a strong signal on
the normal copy of chromosome 4, while signals on
the derivative chromosomes were of lesser strength
(Fig.3E). The green fluorescent signals were found
exclusively on the normal copy of chromosome 13
and the der(4)(Fig.3F), indicating that Pool 13-4 to
Pool 13-6 bound distal of the breakpoint on chromo-
some 13. 
We then decided to map Pool 13-3 knowing that
the breakpoint on chromosome 13 lies proximal of
Pool 13-4, but within or distal of Pool 13-2. Dual
color FISH using a combination of biotinylated Pool
13-3 DNA and dig.-labeled Pools 4-1 plus 4-2
showed the expected signals on the normal non-
rearranged copies of chromosomes 4 and 13 (Fig.
3G). Red and green signals were found on both
derivative chromosomes indicated that Pool 13-3
spans the chromosome 13-specific breakpoint in T-
0512. We also noted that the green signal on the
der(4) chromosome was faint (arrow in Fig. 3G),
while the green signal on the der(13) was strong
(arrowhead, Fig. 3G). Thus, only a small fraction of
probe from Pool 13-3 bound distal of the breakpoint,
and most of this probe pool bound proximal.
In conclusion, only three overnight FISH experi-
ments with BAC pools and patient metaphase
spreads allowed us to narrow the breakpoint position
on chromosome 13 to a 1.1 Mbp interval between
62.5 Mbp and 63.6 Mbp. The next step in the PGD
probe preparation process was probe optimization:
since the chromosome 4-specific DNA probe contigs
was split about 3:2 to 2:1 (Fig. 3B), we decided to
design a chromosome 13-specific BAC pool probe
that will be split asymmetrically by the transloca-
tion, thus allowing unambiguous identification of
derivative chromosomes in interphase cell nuclei.
This was achieved easily by combining the previ-
ously prepared biotinylated probe from Pool 13-3
with DNA probes prepared from Pools 13-4, 13-5,
13-5.5, and 13-6 (Table 2) covering an interval from
62.5 Mbp to 67.8 Mbp. The FISH result showed that
signals from biotinylated chromosome 13 probes
were split into two differently sized parts: the signals
derived from pool 13-3 BAC's binding to the proxi-
mal long arm of chromosome 13, i.e., der(13) signals
were weaker than those of probes that covered the
distal part leading to green signals on the der(4)
chromosome (Fig. 3H). This set of hybridization
probes which extents differently on proximal and
distal sites of the chromosome-specific breakpoints
and a simple dual color probe detection scheme
allows classification of all normal homologues and
derivative chromosomes involved in this transloca-
tion in interphase cell nuclei (Fig. 3I).
Discussion
PGD is a well established procedure to identify aneu-
ploid oocytes or chromosomally (ab-)normal embryos
with the purpose to increase the chances of nidation,
pregnancy and birth of a healthy baby [6-8,10]. Unlike
other laboratory tests, PGD is a single cell analysis:
typically, only 1-2 blastomeres are biopsied from day
3 embryos [6, 9]. Interphase cell analysis is possibly
the most important component of PGD, since blas-
tomeres can be in any stage of the cell cycle. For over
a decade, we and others have been using chromosome-
specific DNA repeat probes, many of which are com-
mercially available, to enumerate a limited number of
chromosomes in individual interphase nuclei [8,23,
31-32]. Many of these chromosome enumerator probes
(CEPs) target alpha satellite DNA repeats at or near the
chromosome centromeres [33,34]. However, in cells
from carriers of a reciprocal translocation, in which the
prevalence of unbalanced gametes carrying a partial
aneusomy ranges from 50% to 70% [7,9,35], the cen-
tromeric probes miss most abnormalities.
To address this issue, we initially prepared DNA
probe contigs comprised of YACs that bilaterally
extended individual translocation breakpoints [12-16].
With the time constraints in IVF programs, often little
time was left for probe optimization [14]. Thus, our
present work focuses on choosing BAC clones rather
than YACs, because the former ones have a number of
significant advantages such as less chimerism or faster
growth. Another aim of our study was to expedite the
process of mapping translocation breakpoints by elim-
inating so-called hybridization failures through 
the pooling BAC clones. 
In our FISH mapping scheme of translocation break-
points, the normal homologues show hybridization
domains in a single color. For example, red fluorescent
signals delineate the hybridization target on normal
homologues of chromosome 4 or green signals specifi-
cally mark chromosome 13 (Fig. 3). If probe binding
extents significantly on both sides of the breakpoint
(i.e., it spans or extends the breakpoint region), probe
signals will be found on one or both derivative chromo-
somes and signals are comprised of mixed colors.
Historically, breakpoint mapping is an iterative
process based on the definition of the smallest interval
between proximal and distal probes. Thus, many of the
DNA probes prepared in breakpoint mapping experi-
ments did not generate additional information [12-16].
Importantly, our pooling protocol for PGD probe
preparation accelerates the delineation and fine map-
ping of translocation breakpoints without sacrificing
resolution. The turnaround time for each cycle com-
prised of clone selection, FISH and image analysis
using patient samples can now be as short as 3-4 days.
Thus, with translocation breakpoints roughly deter-
mined by G-banding, large numbers of BACs can be
373From blood to BAC in 20 days
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2009:47(3): 373 (367-375) 
10.2478/v10042-009-0067-2
pulled from in-house libraries and assembled in probe
pools before initiation of the IVF cycle. As the exam-
ple in this paper shows, only a few overnight
hybridizations will be required to localize the break-
point to a single pool and optimize the probes for sin-
gle cell interphase analysis. Thus, the proposed BAC
pooling strategy seems capable to provide breakpoint
information as well as DNA probes suitable for inter-
phase cell analysis in only 2-3 weeks, a significant
improvement over previous methods [13].
In many instances, the costs of IVF cycles and
PGD, often tens of thousands of US dollars per cycle,
are borne by the patients. We believe, our approach
will not only lead to reduced costs making interphase
PGD more affordable to infertile couples, but also
result in more reliable PDG procedures, reduce the
number of failed embryo transfers and the suffering
associated with failed transfers.
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